Ova-Mit Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Clomifene citrate

Indications/Uses

Ovulatory failure in women desiring pregnancy.

Click to view Ova-Mit detailed prescribing information

Dosage/Direction for Use

50 mg daily for 5 days, starting on or about the 5th day of menstrual cycle or at any time if there is amenorrhea. If ovulation does not occur, a course of 100 mg daily for 5 days may be given.

Click to view Ova-Mit detailed prescribing information

Overdosage

View Ova-Mit overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Patients w/ liver disease or history of liver dysfunction; hormone-dependent tumours; abnormal uterine bleeding of undetermined origin; presence of an ovarian cyst, except polycystic ovary. Pregnancy.

Click to view Ova-Mit detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Ova-Mit detailed prescribing information

Special Precautions

Examine patients before starting treatment to exclude liver disease, pituitary or ovarian failure & neoplasms of the endometrium. Cause of infertility & any abnormal bleeding should be investigated. Possibility of multiple births. Prolonged courses of treatment are not recommended. Visual symptoms may occasionally occur during treatment. Ineffective in patients w/ primary pituitary or primary ovarian failure. Not a substitute for appropriate therapy of other conditions which may cause ovulatory dysfunctions (eg, thyroid or adrenal disease). Not a 1st line treatment for low wt-related amenorrhea w/ infertility; no value if high FSH blood level is observed following an early menopause. Record basal temp throughout all treatment cycles; discontinue therapy if pregnancy is suspected.

Click to view Ova-Mit detailed prescribing information

Use In Pregnancy & Lactation

Click to view Ova-Mit detailed prescribing information

Storage

View Ova-Mit storage conditions for details to ensure optimal shelf-life.

Description

View Ova-Mit description for details of the chemical structure and excipients (inactive components).

Action

View Ova-Mit mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Trophic Hormones & Related Synthetic Drugs

ATC Classification

G03GB02 - clomifene ; Belongs to the class of synthetic agents used as ovulation stimulants.

Regulatory Classification

Presentation/Packing

Form

Ova-Mit tab 50 mg

Packing/Price

10's

Ova-Mit

clomifene

Manufacturer:

Remedica

Distributor:

Corbridge